Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
AGN
Allergan plc
AGN
|
+$603M |
| 3 |
Meta Platforms (Facebook)
META
|
+$459M |
| 4 |
Alibaba
BABA
|
+$361M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49B |
| 2 |
Qualcomm
QCOM
|
+$424M |
| 3 |
Oracle
ORCL
|
+$369M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$351M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.16% |
| 2 | Financials | 5.29% |
| 3 | Healthcare | 5.26% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Communication Services | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
PUT
Puma Biotechnology
PBYI
$404M
| $1.08M | ﹤0.01% |
100,400
+70,100
| +231% | +$757K |
|
3502
Vermilion Energy
VET
$1.82B
| $1.08M | ﹤0.01% |
64,837
-1,624
| -2% | -$28.2K |
|
3503
Tanger
SKT
$4.67B
| $1.08M | ﹤0.01% |
69,832
-19,088
| -21% | -$299K |
|
3504
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$741M
| $1.08M | ﹤0.01% |
24,410
+7,043
| +41% | +$319K |
|
3505
CALL
Wabtec
WAB
$49.1B
| $1.08M | ﹤0.01% |
15,000
-100,000
| -87% | -$7.11M |
|
3506
AMC Entertainment Holdings
AMC
$2.52B
| $1.08M | ﹤0.01% |
10,061
-1,055
| -9% | -$115K |
|
|
MDR
3507
DELISTED
McDermott International
MDR
| $1.08M | ﹤0.01% |
533,569
+15,871
| +3% | +$97.5K |
|
3508
CALL
Myriad Genetics
MYGN
$270M
| $1.08M | ﹤0.01% |
37,600
+31,900
| +560% | +$930K |
|
|
BBT
3509
Beacon Financial Corp
BBT
$2.66B
| $1.07M | ﹤0.01% |
36,708
+504
| +1% | +$15.3K |
|
3510
Cimpress
CMPR
$2.39B
| $1.07M | ﹤0.01% |
8,152
-3,020
| -27% | -$332K |
|
3511
Xtrackers Municipal Infrastructure Revenue Bond ETF
RVNU
$142M
| $1.07M | ﹤0.01% |
38,000
| – | – |
|
3512
CALL
Zebra Technologies
ZBRA
$14B
| $1.07M | ﹤0.01% |
5,200
+2,800
| +117% | +$566K |
|
|
CHX
3513
DELISTED
ChampionX
CHX
| $1.07M | ﹤0.01% |
39,581
-16,574
| -30% | -$484K |
|
3514
CALL
iShares MSCI Turkey ETF
TUR
$200M
| $1.07M | ﹤0.01% |
40,100
+25,900
| +182% | +$654K |
|
3515
United Parks & Resorts
PRKS
$2.1B
| $1.07M | ﹤0.01% |
40,673
-28,510
| -41% | -$868K |
|
|
CCH.U
3516
DELISTED
Collier Creek Holdings Units, each consisting of one Class A ordinary share, $0.0001 par value, and
CCH.U
| $1.07M | ﹤0.01% |
100,000
| – | – |
|
3517
Carter's
CRI
$1.42B
| $1.07M | ﹤0.01% |
11,717
+4,325
| +59% | +$394K |
|
3518
CALL
Church & Dwight Co
CHD
$23.4B
| $1.07M | ﹤0.01% |
14,200
+6,700
| +89% | +$507K |
|
3519
CALL
Canadian Natural Resources
CNQ
$99.4B
| $1.07M | ﹤0.01% |
81,884
-81,680
| -50% | -$1.01M |
|
3520
CALL
Nektar Therapeutics
NKTR
$2.39B
| $1.07M | ﹤0.01% |
3,907
+1,967
| +101% | +$721K |
|
|
EGRX
3521
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.07M | ﹤0.01% |
18,864
+13,762
| +270% | +$774K |
|
3522
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.67B
| $1.07M | ﹤0.01% |
34,002
+4,259
| +14% | +$136K |
|
3523
FormFactor
FORM
$8.28B
| $1.06M | ﹤0.01% |
57,168
+1,768
| +3% | +$30.2K |
|
|
TIVO
3524
CALL
DELISTED
Tivo Inc
TIVO
| $1.06M | ﹤0.01% |
139,800
-64,900
| -32% | -$496K |
|
|
AYX
3525
CALL
DELISTED
Alteryx Inc
AYX
| $1.06M | ﹤0.01% |
9,900
+9,400
| +1,880% | +$1.17M |
|
Similar funds
Citigroup's Q3 2019 Portfolio in Review
As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
- Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
- Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
- Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
- Citigroup opened 182 new positions and closed 268 in Q3 2019.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.